Viewing StudyNCT06413498



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06413498
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2024-05-09

Brief Title: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed Refractory Multiple Myeloma
Sponsor: Kite A Gilead Company
Organization: Gilead Sciences

Organization Data

Organization: Gilead Sciences
Class: INDUSTRY
Study ID: KT-US-679-0788
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Kite A Gilead Company
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Arcellx Inc INDUSTRY